Ikarian Capital, LLC Tempest Therapeutics, Inc. Transaction History
Ikarian Capital, LLC
- $754 Million
- Q1 2024
A detailed history of Ikarian Capital, LLC transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 105,600 shares of TPST stock, worth $213,312. This represents 0.05% of its overall portfolio holdings.
Number of Shares
105,600
Previous 105,600
-0.0%
Holding current value
$213,312
Previous $412,000
-0.0%
% of portfolio
0.05%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding TPST
# of Institutions
34Shares Held
1.43MCall Options Held
161KPut Options Held
78K-
Black Rock Inc. New York, NY508KShares$1.03 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$355,9090.0% of portfolio
-
Geode Capital Management, LLC Boston, MA132KShares$266,8070.0% of portfolio
-
Fil LTD Hamilton, D0130KShares$261,7490.0% of portfolio
-
Bank Of America Corp Charlotte, NC43KShares$86,9180.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $21M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...